Health ❯Healthcare ❯Clinical Trials

Cancer Research

Glioblastoma Melanoma Trials Immunocore ECHELON-1 Trial PIK3CA Mutations in Breast Cancer Brexit Impact Case Western Reserve University Pembrolizumab Car T-cell Therapy Skin Cancer Vaccines Solid Tumors Translational Oncology Daratumumab Studies Therapeutic Techniques B-cell Acute Lymphoblastic Leukemia Lymphoma Treatments Therapeutic Innovations Tumor Targeting Myeloma Clinical Trials Pediatric Oncology PCT Development Breast Cancer Targeted Therapy Survival Rates Personalized Medicine Innovative Treatments Glioblastoma Treatment

Russia to Begin Patient Doses of Personalized mRNA Cancer Vaccine in Coming Months

The Gamaleya institute is moving its tumor-specific therapy toward human dosing based on each patient’s genetic tumor profile

NICE Approves Keytruda Combo for Advanced Endometrial Cancer on NHS

Dual-Species Bacterial Therapy Destroys Tumors Without Immune Cells

UC San Diego Launches Clinical Trial of Sequenced Radiotherapy and Immunotherapy for Head and Neck Cancer

Celcuity’s Gedatolisib Combos Yield Up to 76% Progression-Free Survival Gain in Phase 3 Trial

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

Nagoya University Advances Eva1-Targeted CAR-T Therapy to Preclinical Safety Testing

Swiss Team Secures Innosuisse Funding to Advance Terbium-161 Lymphoma Treatment

Five-year data show one-time T-cell therapy extends survival in advanced melanoma

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors

Keynote-689 Trial Finds Pembrolizumab Doubles Disease-Free Survival in Head and Neck Cancer

CAPGLO Device Promises Rapid, Low-Cost T Cell Harvesting for CAR T Therapy

Study Highlights Patient-Reported Physical Function as Key Predictor of Daratumumab Success in Multiple Myeloma

NHS England to Introduce Europe’s First Injectable Cancer Immunotherapy

Brexit Red Tape Blocks NHS Cancer Patients from Life-Saving Drugs, Report Finds

NICE Approves Capivasertib for NHS Use in Advanced Breast Cancer Treatment

NICE Approves Brentuximab Vedotin for Advanced Hodgkin Lymphoma on NHS

NHS Introduces First-Ever Treatment for Rare Eye Cancer

Innovative Antibody Shows Promise in Cancer Treatment